1. A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus. (November 2015) Authors: Calderon, C; Zucht, H-D; Kuhn, A; Wozniacka, A; Szepietowski, J C; Nyberg, F; Weichenthal, M; Piantone, A; Budde, P Journal: Lupus Issue: Volume 24:Number 13(2015) Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CPC-151 Type of Cancer and Risk Factors in HIV Patients on Antiretroviral Treatment. (12th March 2013) Authors: Gasanz, I; Moriel, MC; Corrales, L; Miguel, P San; Vazquez, MJ; Segura, M; Rubio, B; Calderon, C; Catalá, RM Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO.6.137 Design of a phase 2, multicenter, randomized, placebo-controlled, parallel-group, double-blind study to assess the efficacy and safety of nipocalimab in adults with active systemic lupus erythematosus. (27th September 2022) Authors: Liu-Walsh, F; Van Hartingsveldt, B; Zuraw, Q; Hoffman, RW; Rooney, T; Gao, S; Gordon, R; Leu, JH; Berhanu Debella, A; Calderon, C; Zazzetti, F; Vratsanos, G Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗